These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Coronary sinus obstruction by primary cardiac lymphoma as a cause of dyspnea due to significant diastolic dysfunction and elevated filling pressures. Park SM; Shim CY; Choi D; Lee JH; Kim SA; Choi EY; Ha JW; Chung N J Am Soc Echocardiogr; 2010 Jun; 23(6):682.e5-7. PubMed ID: 19962276 [TBL] [Abstract][Full Text] [Related]
25. Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma. Craig M; Hanna WT; Cabanillas F; Chen CS; Esseltine DL; Neuwirth R; O'Connor OA Br J Haematol; 2014 Sep; 166(6):920-8. PubMed ID: 25039282 [TBL] [Abstract][Full Text] [Related]
26. Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma. Bermúdez A; Marco F; Conde E; Mazo E; Recio M; Zubizarreta A Haematologica; 2000 Aug; 85(8):894-5. PubMed ID: 10942955 [No Abstract] [Full Text] [Related]
27. [Follicular lymphoma showing long-term false positive results by FDG-PET after rituximab-containing chemotherapy]. Miyazaki Y; Nawa Y; Kohashi S; Nakase K; Miyagawa M; Hara M Rinsho Ketsueki; 2012 Feb; 53(2):252-4. PubMed ID: 22450588 [TBL] [Abstract][Full Text] [Related]
28. Pericardial involvement in a non-Hodgkin lymphoma patient: coregistered FDG-PET and CT imaging. Weijs LE; Arsos G; Baarslag HJ; Wittebol S; de Klerk JM Eur Heart J; 2007 Nov; 28(22):2698. PubMed ID: 17567624 [No Abstract] [Full Text] [Related]
29. Lenalidomide in combination with R-CHOP (R2-CHOP) in patients with high burden follicular lymphoma: phase 2 study. Clin Adv Hematol Oncol; 2014 Feb; 12(2 Suppl 6):12; 14-5. PubMed ID: 24870876 [No Abstract] [Full Text] [Related]
31. Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma. McClanahan F; Hielscher T; Rieger M; Hensel M; Bentz M; Schmidt-Wolf I; Käbisch A; Salwender H; Dürk H; Staiger H; Mandel T; Neben K; Hillengass J; Leo E; Krämer A; Ho AD; Witzens-Harig M Am J Hematol; 2012 Oct; 87(10):E68-71. PubMed ID: 22847344 [No Abstract] [Full Text] [Related]
32. A rare case of primary cardiac lymphoma. Khan-Kheil AM; Mustafa HM; Anand DV; Banerjee P BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26538249 [TBL] [Abstract][Full Text] [Related]
33. Secondary prophylaxis of an acute coronary syndrome during rituximab infusion. Triguero Moreno A; Gual Capllonch F; Sancho Cía JM Med Clin (Barc); 2020 Jan; 154(2):69-70. PubMed ID: 31178296 [No Abstract] [Full Text] [Related]
34. Primary diffuse large B-cell lymphoma of the testis relapsing in the right atrium. Yamamoto E; Tomita N; Ishigatsubo Y Br J Haematol; 2015 Feb; 168(4):469. PubMed ID: 25403768 [No Abstract] [Full Text] [Related]
35. [Para-neoplastic autoimmune multi-organ syndrome associated with follicular lymphoma: a case report and literature review]. Chen D; Lin CY; Han X; Chen B; Lu ZH; Chang XY; Duan MH Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1049-1053. PubMed ID: 28088968 [TBL] [Abstract][Full Text] [Related]
36. Clinical and molecular complete remission of primary duodenal follicular lymphoma following treatment with rituximab and cyclophosphamide, vincristine and prednisone chemotherapy. Falorio S; Angrilli F; Fioritoni G Intern Med J; 2009 Oct; 39(10):706-7. PubMed ID: 19849763 [No Abstract] [Full Text] [Related]
37. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET. Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911 [TBL] [Abstract][Full Text] [Related]
39. CHOP chemotherapy followed by Rituximab consolidation as first line treatment in patients with follicular lymphoma. Long-term follow-up of a phase 2 trial. Jäger G; Quehenberger F; Linkesch W; Neumeister P Eur J Haematol; 2007 May; 78(5):453-5. PubMed ID: 17419745 [No Abstract] [Full Text] [Related]
40. Rituximab-induced serum sickness in a patient with follicular lymphoma. Disperati P; Hicks LK; Buckstein R Leuk Lymphoma; 2007 Aug; 48(8):1633-5. PubMed ID: 17701597 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]